Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Immunoelectrophoresis; crossed (2-dimensional assay)

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

Immunoelectrophoresis, crossed or two-dimensional, is a sophisticated laboratory technique that combines two distinct methods: conventional electrophoretic separation and electroimmunodiffusion. In the first phase of the procedure, electrophoresis is conducted to separate proteins based on their size and charge. Following this initial separation, the protein strip is placed onto a slide that contains an agarose solution infused with specific antibodies. This agarose solution is allowed to solidify, creating a stable medium for the next step. The second phase involves performing electrophoresis again, but this time at a right angle to the original separation. This two-dimensional approach allows for a more detailed analysis of the proteins, as it enables the identification and characterization of various protein components within a sample. The technique is particularly useful in diagnosing and monitoring certain diseases by providing insights into the protein composition of biological fluids.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

Immunoelectrophoresis, crossed (2-dimensional assay) is performed for various clinical indications, particularly when there is a need to analyze and identify specific proteins in biological samples. The following conditions may warrant the use of this procedure:

  • Protein abnormalities Identification of abnormal protein patterns that may indicate diseases such as multiple myeloma or other plasma cell disorders.
  • Immune system disorders Evaluation of immune deficiencies or autoimmune diseases by analyzing immunoglobulin levels and subclasses.
  • Infectious diseases Detection of specific antibodies in response to infections, aiding in the diagnosis of certain infectious diseases.

2. Procedure

The procedure for crossed immunoelectrophoresis involves several critical steps that ensure accurate separation and identification of proteins. Each step is essential for the successful execution of the assay.

  • Step 1: Initial Electrophoresis The process begins with the application of a biological sample, such as serum or urine, onto a gel medium. An electric current is then applied, causing the proteins within the sample to migrate through the gel. This migration separates the proteins based on their size and charge, creating distinct bands that represent different protein components.
  • Step 2: Preparation of Agarose Slide After the initial electrophoresis, the gel strip containing the separated proteins is carefully placed onto a slide that has been prepared with an agarose solution containing specific antibodies. This agarose solution is crucial as it provides a medium for the subsequent immunodiffusion process.
  • Step 3: Solidification The agarose solution is allowed to solidify, which stabilizes the protein bands in place. This solidification is a critical step as it ensures that the proteins remain fixed during the next phase of the procedure.
  • Step 4: Second Electrophoresis Once the agarose has solidified, a second electrophoresis is performed at a right angle to the original separation. This two-dimensional approach allows for the interaction between the proteins and the antibodies, facilitating the identification of specific proteins based on their binding characteristics.

3. Post-Procedure

After the completion of the crossed immunoelectrophoresis procedure, the slide is analyzed to interpret the results. The expected outcome includes the visualization of distinct bands that indicate the presence and concentration of specific proteins. These results are crucial for diagnosing various conditions, and further analysis may be required to confirm findings. It is important to ensure proper documentation of the results and any relevant clinical information to support the interpretation of the assay. Additionally, follow-up may be necessary based on the findings, which could include further testing or monitoring of the patient's condition.

Short Descr IMMUNOELECTROPHORESIS ASSAY
Medium Descr IMMUNOELECTROPHORESIS CROSSED
Long Descr Immunoelectrophoresis; crossed (2-dimensional assay)
Status Code Active Code
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 6 - Laboratory Physician Interpretation Code
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE Not applicable/unspecified.
CCS Clinical Classification 235 - Other Laboratory
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
GA Waiver of liability statement issued as required by payer policy, individual case
Date
Action
Notes
2024-12-31 Deleted Code Deleted.
Pre-1990 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"